— Researchers say treatment has fewer side effects and less risk of rejection, too.
Hepatitis C in the News Your source for hepatitis C-related news from around the web.
Not sure what to submit? Read our news guidelines first.
— First human tests looked at safety.
— Researchers conclude Sovaldi is cost-effective.
— Combination pill, taken once a day, blocks enzymes that virus needs to multiply.
The drug simeprevir (trade name: Olysio) has been available since May 2014 for the treatment of adult patients with chronic hepatitis C infection. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency in…
— Viral infection comes from contaminated food, water or contact with infected person.
Federal approval of new drugs to treat the hepatitis C virus (HCV) represents "a dramatic, positive development for patients," says University at Buffalo liver disease expert Andrew H. Talal, MD. In October, the U.S. Food and Drug Administration approved the first HCV treatments that cure patients without interferon.
— Heavier people might be more prone to liver cancer, insulin problems, researchers say.
— New study echoes prior findings and suggests caffeine isn't the key ingredient in the effect.
— Broader organ sharing in U.S. will result in more air travel, researchers say.